Relevant bibliographies by topics / Heart failure outcomes

Academic literature on the topic 'Heart failure outcomes'

Author: Grafiati
Published: 9 March 2023
Last updated: 10 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Heart failure outcomes.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Heart failure outcomes"

1

Coen, Jennifer, and Kimberly Curry. "Improving Heart Failure Outcomes." Critical Care Nursing Quarterly 39, no. 4 (2016): 335–44. http://dx.doi.org/10.1097/cnq.0000000000000127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Darsaklis, Konstadina, Sophia Farooki, Viviane Nguyen, and Nadia Giannetti. "New Heart Failure Score Predicts Outcomes in Heart Failure Patients." Journal of Cardiac Failure 15, no. 6 (August 2009): S93. http://dx.doi.org/10.1016/j.cardfail.2009.06.091.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rasmusson, Kismet. "Heart failure self-management instruction: Impact on heart failure outcomes." Heart & Lung 40, no. 1 (January 2011): 2–3. http://dx.doi.org/10.1016/j.hrtlng.2010.10.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Paul, Sara. "Improving Outcomes in Heart Failure." Critical Care Nursing Quarterly 24, no. 4 (February 2002): 83. http://dx.doi.org/10.1097/00002727-200202000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Moser, Debra K., and Douglas L. Mann. "Improving Outcomes in Heart Failure." Circulation 105, no. 24 (June 18, 2002): 2810–12. http://dx.doi.org/10.1161/01.cir.0000021745.45349.bb.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Benatar, Daniel, Mary Bondmass, Jaime Ghitelman, and Boaz Avitall. "Outcomes of Chronic Heart Failure." Archives of Internal Medicine 163, no. 3 (February 10, 2003): 347. http://dx.doi.org/10.1001/archinte.163.3.347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cohen, Laura P., Jeffrey D. Wessler, Mathew S. Maurer, and Scott L. Hummel. "Salt Taste Sensitivity and Heart Failure Outcomes Following Heart Failure Hospitalization." American Journal of Cardiology 127 (July 2020): 58–63. http://dx.doi.org/10.1016/j.amjcard.2020.04.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Standl, Eberhard, and Oliver Schnell. "Heart failure outcomes and Covid-19." Diabetes Research and Clinical Practice 175 (May 2021): 108794. http://dx.doi.org/10.1016/j.diabres.2021.108794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Torosoff, Mikhail, and Edward F. Philbin. "Improving outcomes in diastolic heart failure." Postgraduate Medicine 113, no. 3 (March 2003): 51–58. http://dx.doi.org/10.3810/pgm.2003.03.1388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pressler, S. J., I. Gradus-Pizlo, S. D. Chubinski, G. Smith, S. Wheeler, J. Wu, and R. Sloan. "Family Caregiver Outcomes in Heart Failure." American Journal of Critical Care 18, no. 2 (March 1, 2009): 149–59. http://dx.doi.org/10.4037/ajcc2009300.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Heart failure outcomes"

1

Jensen, Gwenneth Anne. "Outcomes of heart failure discharge instructions." Diss., University of Iowa, 2011. https://ir.uiowa.edu/etd/3318.

Full text
Abstract:
Acute decompensation of chronic heart failure is common and results in many patients being re-hospitalized every year (Jancin 2008). One of four voluntary core measures deployed by the Joint Commission for evaluation of quality of heart failure care in hospitals is heart failure discharge instructions, also called core measure HF1. Although the core measure is a widely disseminated standardized measure related to discharge education, there is little evidence about its impact on patient or readmission outcomes. The purpose of this study was to determine the relationship between the completion of heart failure discharge instructions as defined by the Joint Commission core measure HF1 in a single site, 500 bed tertiary hospital population in the Upper Midwest and the primary endpoint of subsequent readmission to the hospital 30, 90, 180 and 365 days following an index discharge for primary diagnosis of heart failure. Secondary endpoints included hospital readmission charges and total hospital readmission days per year. Patient characteristics, clinical characteristics, unit factors and index visit utilization variables were controlled. This study also described the relationship between nursing unit factors and completion of HF1. A retrospective, descriptive design, and analyses using primarily generalized linear models, were used to study the relationship of HF1 to utilization outcomes (readmission, hospital days and cost) and unit context (discharge unit and number of inter-unit transfers). Individual level retrospective demographic, clinical, administrative and performance improvement data were used (n = 1034). Results suggested a weak and non-significant association of completion of the core measure HF1 bundle and readmission within 30 days for all cause readmissions (p = .22; OR 1.32), and no association with HF to HF readmissions at 30 days. There was an inverse association 2 after 6 months for all cause readmission, and after 90 days for HF to HF readmission. There was a non-significant trend toward a relationship to total hospital days, but no relationship of HF1 to total annual charges. The study did find a significant relationship between type of discharge nursing unit and HF1 completion, and type of discharge unit and readmission. The discharge nursing unit was quite consistently and strongly related to all cause readmissions in binary (p = .029: OR 1.58) and counts analyses (p = .001; OR 1.52), but was not related to the subset of HF to HF readmissions. The study concludes that there is limited relationship between HF1 and 30 day all cause hospital readmission and total readmission days, but a stronger relationship between HF1 and discharge from a cardiology specialty unit. There was also a relationship between cardiology discharge unit and reduction in all cause readmissions.
APA, Harvard, Vancouver, ISO, and other styles
2

Collins, Diana Lee. "Improving Outcomes for Congestive Heart Failure Patients." ScholarWorks, 2018. https://scholarworks.waldenu.edu/dissertations/5688.

Full text
Abstract:
Managing patients diagnosed with congestive heart failure (CHF) requires coordination with subspecialties and frequent outpatient monitoring. The lack of communication among health care providers and patients can result in a gap in practice when managing patients with CHF in the outpatient setting. Guided by the chronic care model, this quality improvement project was an initiative to develop and implement a 6-week self-care management program provided by nurse practitioners in an outpatient primary care practice. The goal of the project was to improve the day-to-day self-care management of patients with CHF and addressed the practice-focused question of whether a 6-week CHF program offered in the outpatient setting would result in better symptom management due to patients' enhanced adherence to treatment plans. A total of 10 patients participated in the 6-week program, and all participants demonstrated improvement in their CHF symptoms, which allowed them to be reclassified into a lower class on the New York Heart Association's CHF staging system. Of the 10 participants, 7 were completely compliant with attending weekly visits, performing daily journaling, and adhering to dietary recommendations and medication management; 3 participants demonstrated less compliance with the self-care recommendations during the program, but also showed sufficient improvement in symptoms to be reclassified. The project demonstrated the potential for reducing the symptom burden of CHF through proactive outpatient management, contributing to positive social change by improving the quality of life for these patients. Nurse practitioners may find the program description helpful for developing similar initiatives in their clinical settings.
APA, Harvard, Vancouver, ISO, and other styles
3

Akhatova, Elena. "Do clinical pharmacy servicesimprove outcomes for patientswith heart failure (HF)? : Do clinical pharmacy servicesimprove outcomes for patientswith heart failure (HF)?" Thesis, Umeå universitet, Kemiska institutionen, 2015. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-106301.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Inkrot, Simone [Verfasser]. "Patient-reported outcomes in heart failure / Simone Inkrot." Berlin : Medizinische Fakultät Charité - Universitätsmedizin Berlin, 2016. http://d-nb.info/1100388184/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Chang, Sungwon. "An integrated approach to outcome evaluation : incorporating patient reported outcomes in heart failure." Thesis, Curtin University, 2012. http://hdl.handle.net/20.500.11937/2606.

Full text
Abstract:
Globally individuals and health care systems are facing the burden of chronic illness. The impact of the increasing burden of non-communicable diseases is experienced by individuals and health care systems. Across the globe health care systems are struggling to meet the increasing demands for services within the confines of rising costs and needs for accountability. Beyond costs and treatment allocations, there is an increasing mandate to provide care that is patient centred and appropriate to the needs of the individual. The Innovative Care in Chronic Condition (ICCC) framework has been successful in driving health care reforms to meet the needs of individuals with chronic illness internationally. Deriving metrics that allow monitoring of conditions at the level of the patient, provider and health care system are of increasing importance. Comprising this thesis is a series of studies to investigate outcomes that includes the patient’s perspective in the evaluation of clinical interventions. To achieve this, chronic heart failure, was used as an exemplar of a chronic condition.Chronic heart failure (CHF) is the final common pathway for many cardiac conditions. As a consequence has emerged as a major public health problem and represents as an excellent exemplar of living with a chronic illness. CHF patients commonly experience high levels of ill-health, disability and mortality placing a heavy burden on health care systems. Hospitalisations are frequent and costly to both CHF patients and to society. People with CHF live with a limited quality of life and physical ability and the prognosis for CHF is poor. Given the nature of debilitating symptoms, and their potential impact on physical, social and psychological aspects of life, patient’s perspective in outcome assessment is essential in providing effective care.Specifically this study sought to: •Examine patient reported outcomes in clinical management and in clinical research •Investigate patient important outcomes, their utility, relevance and acceptability amongst patients, clinicians, researchers and administrators •Test composite outcomes model that integrate patient important outcomes in clinical trials researchPatient reported outcomes (PROs) is a strategy to capture the patient perspective and experience on their health status. The use of PROs can be incorporated in clinical assessments, monitoring of clinical progress as well as clinical research. Despite their frequent use in research, evidence suggests that to date they have had a limited influence on clinical practice and policy. As part of this thesis an integrative review was conducted to explore the potential utility of PROs at the policy level. By using the ICCC framework, PROs were indeed essential to improve the management of CHF at the micro, meso and macro levels of decision making.One of the key challenges in using PROs and outcomes important to individuals in CHF is limited methodological and reporting quality. This is cited as a reason why many clinicians are sceptical of the utility of PROs. To explore issues in reporting a review was conducted on RCTs of pharmacological therapy in CHF that reported health related quality of life (HRQoL) as a primary or secondary outcome. Using the Minimum Standard Checklist for evaluating the quality of reporting of HRQoL outcomes resulted in 26 (19.1%) studies being considered ‘very limited’ in terms of methodological and reporting rigour, and 91 (66.9%) were evaluated as ‘limited’ and only 19 (14.0%) studies were considered to be of a ‘probably robust’ quality. In fact, the quality of HRQoL reporting has not improved over time. Some of the issues identified are limited discussions, methodological shortcomings, and poor HRQoL reporting. This review has underscored the importance of standardising of the reporting of HRQoL measures.Although capturing the patient’s perspective via PROs is important, they may not be the only outcome measures important to patients. Currently, no single CHF outcome measure captures all dimensions of the quality of care from the patient’s perspective. To identify outcome measures in CHF deemed important to patients, a structured literature review was undertaken. The conceptual and methodological challenges and opportunities in each outcome measure were identified as important to patients with CHF. That is mortality, hospitalisation and PROs were identified as important to patients but also meaningful and relevant to the provider and health care system as well. These outcome measures were proposed as a core outcome set that represent the minimum set of outcomes that should be measured and reported in CHF.A number of composite outcome measures have been developed to capture the perspective of the patient, clinician as well as including objective measures of health. Three validated composite outcomes, the Packer’s Score, Cleland’s Patient Journey and the composite endpoint used in the African American Heart Failure Trial (A-HeFT) were examined in a secondary analysis of a prospective, multi-center randomized controlled trial of 280 hospitalized CHF patients in the Which Heart failure Intervention is most Cost-effective & Consumer Friendly in Reducing Hospital Care (WHICH?) Trial in order to assess the comparability and interpretability of the measures in a pragmatic clinical trial. Correlation coefficients demonstrated substantial associations amongst all three composite endpoints. Although there was a considerable agreement across the three measures when estimating deteriorating condition, these was less when estimating improvements.This thesis has described both the importance and complexity of including outcome measures that are meaningful to patients in both the assessment of individuals’ needs, testing interventions, monitoring outcomes and assessing process and outcome measures at a health systems level. This thesis has also extended the discussion and debate around PROs to discuss Patient Important Outcomes, which is outcomes that patients notice and for which they would be willing to undergo a treatment with associated risk, cost, or inconvenience for it to be the only thing that changed. Using CHF as an exemplar has provided useful insights into the dimensions and complexities of measuring outcomes in chronic and complex conditions. As the burden of chronic disease continues to increase refining the metrics of outcome measurements will be equally as important as refining novel therapies. This will be critical to develop and implement interventions to meet the growing numbers of people living with chronic illness.
APA, Harvard, Vancouver, ISO, and other styles
6

Kadri, Amer N., Vivek Menon, Yasser M. Sammour, Rama D. Gajulapalli, Chandramohan Meenakshisundaram, Leen Nusairat, DIvyanshu Mohananey, et al. "Outcomes of patients with severe tricuspid regurgitation and congestive heart failure." BMJ Publishing Group, 2019. http://hdl.handle.net/10757/652470.

Full text
Abstract:
Objectives A substantial number of patients with severe tricuspid regurgitation (TR) and congestive heart failure (CHF) are medically managed without undergoing corrective surgery. We sought to assess the characteristics and outcomes of CHF patients who underwent tricuspid valve surgery (TVS), compared with those who did not. Methods Retrospective observational study involving 2556 consecutive patients with severe TR from the Cleveland Clinic Echocardiographic Database. Cardiac transplant patients or those without CHF were excluded. Survival difference between patients who were medically managed versus those who underwent TVS was compared using Kaplan-Meier survival curves. Multivariate analysis was performed to identify variables associated with poor outcomes. Results Among a total of 534 patients with severe TR and CHF, only 55 (10.3%) patients underwent TVS. Among the non-surgical patients (n=479), 30% (n=143) had an identifiable indication for TVS. At 38 months, patients who underwent TVS had better survival than those who were medically managed (62% vs 35%; p<0.001). On multivariate analysis, advancing age (HR: 1.23; 95% CI 1.12 to 1.35 per 10-year increase in age), moderate (HR: 1.39; 95% CI 1.01 to 1.90) and severe (HR: 2; 95% CI 1.40 to 2.80) right ventricular dysfunction were associated with higher mortality. TVS was associated with lower mortality (HR: 0.44; 95% CI 0.27 to 0.71). Conclusion Although corrective TVS is associated with better outcomes in patients with severe TR and CHF, a substantial number of them continue to be medically managed. However, since the reasons for patients not being referred to surgery could not be ascertained, further randomised studies are needed to validate our findings before clinicians can consider surgical referral for these patients.
Revisión por pares
APA, Harvard, Vancouver, ISO, and other styles
7

Nagpal, Seema. "Factors Influencing Outcomes of Heart Failure: A Population Health Approach." Thèse, Université d'Ottawa / University of Ottawa, 2011. http://hdl.handle.net/10393/20242.

Full text
Abstract:
Background: Symptomatic heart failure is a chronic and disabling condition that affects over 350 000 Canadians and is characterized by inevitable progression. Historically, research on the ways to increase survival has focused on biomedical factors. However, the continued poor prognosis of heart failure has prompted the search for other ways to improve the lives of these patients. Research in other chronic conditions demonstrates that social circumstances, described collectively as individual social interactions (e.g. social support, social participation) and community social factors (e.g. social capital, social norms), can influence health outcomes. Purpose: The purpose of this research was to describe and assess the impact of selected social circumstances potentially related to heart failure outcomes. Methods: Two literature reviews and one empirical study were performed. Conceptual models were proposed to describe the hypothesized pathways between selected social circumstances and heart failure outcomes. The first review was a systematic review of quantitative studies evaluating the relationship between social support and both rehospitalization and death. The review included a critical analysis of the methods employed by previous studies. The second review integrated the qualitative and quantitative literature describing the relationship between individual social interactions (including support, roles and participation) and the quality of life of patients or experience of living with heart failure. A narrative summary was provided and an integration of findings from both qualitative and quantitative study designs was performed. In the empirical study, patients‘ demographic and clinical information was examined simultaneously with selected community factors in a multilevel analysis. Outcomes of interest included rehospitalization or death of heart failure patients. Results: The systematic review shows that previous quantitative research has linked social support to reduced rehospitalization, but there is little evidence to link it with prolonged survival. The critique of the methods describes an inadequate conceptualization and inconsistent measurement of social support. A conceptual model showing how social support can influence rehospitalization is proposed. The integrative review presents qualitative research that identified the following social interactions as important components of the heart failure experience: social support, social participation and role fulfillment. However, no quantitative relationship between social support and quality of life was found. The potential reasons for the discrepant findings between the qualitative and quantitative studies include: the focus on social support as the only component of social interactions assessed in the quantitative literature; and the inconsistent measurement of social support. A conceptual model is presented to describe the multiple components of social interactions and the theoretical basis for their effects. The multilevel analysis demonstrates that individual factors exerted the strongest effect on heart failure outcomes in most models. Community characteristics had little influence on rehospitalization or death. Study design and analysis issues are proposed to explain these findings. Conclusion: The literature reviews and the empirical study provide a contribution to the population health literature, offering a broad approach to assessing the determinants of disease progression in heart failure patients. This thesis research advances the discussion about which social circumstances may influence heart failure outcomes and their pathways. The use of the proposed conceptual models in future research will help clarify the role of social circumstances in the prognosis of heart failure.
APA, Harvard, Vancouver, ISO, and other styles
8

Dobre, Daniela. "Treatment of heart failure and patient outcomes in real life." [S.l. : [Groningen : s.n.] ; University Library Groningen] [Host], 2006. http://irs.ub.rug.nl/ppn/298098539.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

O'Malley, Patricia Anne. "Hemodynamic outcomes of weaning intraaortic balloon counterpulsation in heart failure." The Ohio State University, 2000. http://rave.ohiolink.edu/etdc/view?acc_num=osu1363169617.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Takabayashi, Kensuke. "Clinical Characteristics and Outcomes of Heart Failure Patients With Long-Term Care Insurance -Insights From the Kitakawachi Clinical Background and Outcome of Heart Failure Registry-." Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/265165.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Heart failure outcomes"

1

Heart failure: Strategies to improve outcomes. Minneapolis, Minn: Cardiotext Publ., 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Stewart, Simon, and Lynda Blue, eds. Improving Outcomes in Chronic Heart Failure. London, UK: BMJ Publishing Group, 2004. http://dx.doi.org/10.1002/9780470750551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Simon, Stewart, and Blue Lynda, eds. Improving outcomes in chronic heart failure: Specialist nurse intervention from research to practice. 2nd ed. London: BMJ Books, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Comparative guide to American hospitals: 4,383 hospitals with key personnel and 24 quality measures in treating heart attack, heart failure, pneumonia, pregnancy and surgical infection prevention. 4th ed. Millerton, N.Y: Grey House Pub., 2014.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

The Comparative guide to American hospitals: 4,693 hospitals with key personnel and 49 quality measures relating to heart attack, heart failure, pneumonia, childhood asthma, surgical care, medical imaging and patient experience. 3rd ed. Amenia, NY: Grey House Publishing, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

The fatal illness of Frederick the Noble. London: Keynes, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Alpert, Joseph S., Lynne T. Braun, Elizabeth A. Madigan, Barbara J. Fletcher, and ileana L. Piña. Heart Failure: Strategies to Improve Outcomes. Cardiotext Publishing, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

(Editor), Debra K. Moser, and Barbara Riegel (Editor), eds. Improving Outcomes in Heart Failure: An Interdisciplinary Approach. Jones & Bartlett Publishers, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

(Contributor), Khalid Ashai, William Cohn (Contributor), Matthew Forrester (Contributor), Kelly Guglielmi (Contributor), Charles Herzog (Contributor), Rosemary Kelly (Contributor), Rakhi Khanna (Contributor), et al., eds. Cardiac Surgery in Chronic Renal Failure: Clinical Management and Outcomes. Blackwell Publishing Limited, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Blue, Lynda, and Simon Stewart. Improving Outcomes in Chronic Heart Failure: A Practical Guide to Specialist Nurse Intervention. Wiley & Sons, Limited, John, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Heart failure outcomes"

1

Rehman, Ibad Ur, Khadija Iqbal, Vanya Ibrahim, Alaa bakhtyar, and Belan Mikael. "Heart Failure Outcomes and Management." In Heart Transplantation, 111–15. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-17311-0_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Canter, Charles E. "Indications and Outcomes of Heart Transplantation in the Patient with Congenital Heart Disease." In Heart Failure in Congenital Heart Disease:, 87–108. London: Springer London, 2010. http://dx.doi.org/10.1007/978-1-84996-480-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Campbell, Ruth C., and Ali Ahmed. "Chronic Kidney Disease and Heart Failure: Epidemiology and Outcomes." In The Kidney in Heart Failure, 3–11. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-3694-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Jugdutt, Bodh I., Anwar Jelani, Seraj Abualnaja, Nakul Chander Sharma, and Joseph Szeman Wong. "Reperfusion and Vasodilator Therapy in Elderly Patients with STEMI and Heart Failure: Improving Outcomes." In Aging and Heart Failure, 199–220. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4939-0268-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dobbie, Krista, and Kyle Neale. "Palliative Care in MCS Patients: Insights into Current Practice and Outcomes." In Mechanical Support for Heart Failure, 671–89. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-47809-4_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sen, Priyanka, and Selby Oberton. "Outcomes Using LVADs for Destination Therapy." In Mechanical Circulatory Support for Advanced Heart Failure, 209–19. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65364-8_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zucker, Mark Jay, and Hassan Baydoun. "Improving Clinical Outcomes: A Targeted Approach." In Ventricular Assist Devices in Advanced-Stage Heart Failure, 73–96. Tokyo: Springer Japan, 2013. http://dx.doi.org/10.1007/978-4-431-54466-1_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Campbell, Ruth C., and Ali Ahmed. "Chronic Kidney Disease and Heart Failure: Epidemiology and Outcomes." In Managing the Kidney when the Heart is Failing, 1–9. Boston, MA: Springer US, 2012. http://dx.doi.org/10.1007/978-1-4614-3691-1_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Booth, David C., and Navin Rajagopalan. "Recently Approved Pharmacologic Agents to Improve Outcomes in Heart Failure." In Contemporary Cardiology, 105–15. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-19131-3_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mital, Seema. "Genetic Variation and Outcomes in Right Ventricular Congenital Heart Disease." In Right Ventricular Physiology, Adaptation and Failure in Congenital and Acquired Heart Disease, 41–51. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-67096-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Heart failure outcomes"

1

Lena, Alessia, and Robert van den Heuvel. "Cardiac wasting relevant for clinical outcomes in cancer." In Heart Failure 2022, edited by Alessia Lena and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/3d05d88c.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Savarese, Gianluigi, and Robert van den Heuvel. "Delayed initiation of novel GDMTs associated with adverse outcomes in HF patients." In Heart Failure 2022, edited by Gianluigi Savarese and Marc Bonaca. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/369fa939.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Karki, A., R. Reddy, I. Asante, L. Riley, and C. A. Trillo. "The Impact of Heart Failure on Influenza Pneumonia Outcomes." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5217.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zannad, F., J. Butler, GS Filippatos, S. Pocock, W. Jamal, J. Schnee, C. Zeller, M. Brueckmann, SD Anker, and M. Packer. "Cardiovascular and Kidney Outcomes with Empagliflozin in Heart Failure." In Diabetes Kongress 2021 – 55. Jahrestagung der DDG. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1727471.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

McAleavey, N., and I. Menown. "19 Elevated heart rate in recently stabilised heart failure patients and long term cardiac outcomes." In Irish Cardiac Society Annual Scientific Meeting & AGM, Thursday October 5th – Saturday October 7th 2017, Millennium Forum, Derry∼Londonderry, Northern Ireland. BMJ Publishing Group Ltd and British Cardiovascular Society, 2017. http://dx.doi.org/10.1136/heartjnl-2017-ics17.19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Essa, Hani, Emeka Oguguo, Homeyra Douglas, Alice Foster, Lauren Walker, Justine Hadcroft, Julie Bellieu, et al. "132 One year outcomes of heart failure multispecialty multidisciplinary team virtual meetings." In British Cardiovascular Society Virtual Annual Conference, ‘Cardiology and the Environment’, 7–10 June 2021. BMJ Publishing Group Ltd and British Cardiovascular Society, 2021. http://dx.doi.org/10.1136/heartjnl-2021-bcs.129.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Neves, P., T. Pillay, L. Annest, E. Kaiser, A. Beiras-Fernandez, T. Hanke, F. Stahl, et al. "Live Procedure for Ischemic Heart Failure: Contemporary Short- and Mid-Term Outcomes." In 50th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery (DGTHG). Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1725692.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zheng, Alice, Elena Cowan, Legate Philip, Kaushik Guha, Paul R. Kalra, and Geraint Morton. "83 Characteristics and outcomes of patients with suspected heart failure and elevated natriuretic peptides referred to a nice-compliant heart failure clinic." In British Cardiovascular Society Annual Conference ‘Digital Health Revolution’ 3–5 June 2019. BMJ Publishing Group Ltd and British Cardiovascular Society, 2019. http://dx.doi.org/10.1136/heartjnl-2019-bcs.81.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wong, KL, HO Cally, Timmy WK Au, and FAN Katherine. "23 Stroke outcomes in patients with left ventricular assist device." In 2nd Asia Pacific Advanced Heart Failure Forum (APAHFF 2018), 16th November 2018, Hong Kong. BMJ Publishing Group Ltd, British Cardiovascular Society and Asia Pacific Heart Association, 2019. http://dx.doi.org/10.1136/heartasia-2019-apahff.23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Byrne, L., P. Wheen, P. Murray, C. Minelli, D. O’Callaghan, and C. Daly. "20 How does BMI influence heart failure programme outcomes?-Testing the obesity paradox." In Irish Cardiac Society Annual Scientific Meeting & AGM (Virtual), October 1st – 3rd 2020. BMJ Publishing Group Ltd and British Cardiovascular Society, 2020. http://dx.doi.org/10.1136/heartjnl-2020-ics.20.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Heart failure outcomes"

1

liao, xiaoqian, xingyu fan, ziyi wang, shumin huang, and zhixi hu. Prognostic value of heart-type fatty acid binding protein in heart failure: a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0126.

Full text
Abstract:
Review question / Objective: (1)Can heart type fatty acid binding protein effectively predict the prognosis of patients with heart failure? (2)Is high expression of ear type fat acid binding protein associated with poor clinical outcomes in patients with heart failure? Condition being studied: Heart-type fatty acid binding protein (H-FABP) mainly exists in cardiomyocytes and is a potential biomarker of myocardial injury.However, the adverse consequences of heart failure have not been fully analyzed.Therefore, the purpose of this study was to comprehensively evaluate the correlation between H-FABP and the prognosis of heart failure through meta-analysis.
APA, Harvard, Vancouver, ISO, and other styles
2

LI, Peng, Junhong Ren, and Yan Li. Lung ultrasound guided therapy for heart failure: an updated meta-analyses and trial sequential analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, February 2022. http://dx.doi.org/10.37766/inplasy2022.2.0124.

Full text
Abstract:
Review question / Objective: We aim to evaluate the effect of lung ultrasound (LU) guided therapy on the rates of adverse cardiac events (MACE) in heart failure (HF) patients. Condition being studied: Previous studies have found that B-lines assessed by lung ultrasound can be used for risk stratification in patients with HF and to predict the occurrence of adverse cardiac events. Therefore, similar to BNP, lung ultrasound has clinical value in guiding the management of patients with HF. However, the role of LU in guiding HF therapy is still controversial. Moreover, previous study's samples are too small to explain the over clinical outcomes. Besides, previous meta-analyses study did not perform meta-regression and/or subgroup analyses, or further analyze other parameters, such as heart function, quality of life and length of hospital stay.
APA, Harvard, Vancouver, ISO, and other styles
3

Brewer, Joseph, Massimo Capoccia, Dirk Maybauer, Roberto Lorusso, Justyna Swol, and Marc Maybauer. The ProtekDuo Dual Lumen Cannula as Temporary Acute Mechanical Support for Right Heart Failure: A Protocol for a Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0026.

Full text
Abstract:
Review question / Objective: Participants: Adult patients with right ventricular failure; Intervention: Right ventricular assist device with ProtekDuo cannula; Comparison: Control group of medical management or another type of RVAD (if available); Outcomes: Effectiveness of treatment in terms of survival and complications; Study design: Randomized controlled trials, prospective cohort studies, retrospective cohort studies, case series with >/=5 patientsProspective and retrospective cohort studies, case series of >/= 5 patients. Condition being studied: Right ventricular failure. Information sources: Databases: MEDLINE, Embase, Scopus.
APA, Harvard, Vancouver, ISO, and other styles
4

Lew, Chong Zhi, and Ting Chi Yeh. Pediatric Extracranial Germ Cell Tumor: Clinical Perspective of Autologous Hematopoietic Cell Transplantation. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0081.

Full text
Abstract:
Review question / Objective: A large number of systematic reviews and meta-analyses (SRs/MAs) involving sodium-glucose cotransporter-2 inhibitors (SGLT-2is) in the treatment of heart failure with preserved ejection fraction (HFpEF) have different outcomes. Condition being studied: The efficacy of SGLT-2is on HFpEF is currently a hot topic. However, the results of SRs/MAs conducted on relevant randomized controlled trials (RCTs) are inconsistent. We aim to conduct an umbrella review of existing SRs/MAs, to comprehensively evaluate study quality, and to incorporate calculated data from RCTs to update the results of primary outcomes.
APA, Harvard, Vancouver, ISO, and other styles
5

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), March 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text
Abstract:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Key Informants. We searched MEDLINE and EMBASE (via EMBASE.com), In-Process MEDLINE and PubMed unique content (via PubMed.gov), and the Cochrane Database of Systematic Reviews for systematic reviews or controlled trials. We also searched ClinicalTrials.gov for ongoing studies. We assessed risk of bias and extracted data on health outcomes, surrogate outcomes, usability, sustainability, cost-effectiveness outcomes (quantifying the tradeoffs between health effects and cost), process outcomes, and other characteristics related to PGHD technologies. For isolated effects on health outcomes, we classified the results in one of four categories: (1) likely no effect, (2) unclear, (3) possible positive effect, or (4) likely positive effect. When we categorized the data as “unclear” based solely on health outcomes, we then examined and classified surrogate outcomes for that particular clinical condition. Findings. We identified 114 unique studies that met inclusion criteria. The largest number of studies addressed patients with hypertension (51 studies) and obesity (43 studies). Eighty-four trials used a single PGHD device, 23 used 2 PGHD devices, and the other 7 used 3 or more PGHD devices. Pedometers, blood pressure (BP) monitors, and scales were commonly used in the same studies. Overall, we found a “possible positive effect” of PGHD interventions on health outcomes for coronary artery disease, heart failure, and asthma. For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight) as likely no effect. For hypertension, we rated the health outcomes as unclear, and the surrogate outcomes (systolic BP/diastolic BP) as possible positive effect. For cardiac arrhythmias or conduction abnormalities we rated the health outcomes as unclear and the surrogate outcome (time to arrhythmia detection) as likely positive effect. The findings were “unclear” regarding PGHD interventions for diabetes prevention, sleep apnea, stroke, Parkinson’s disease, and chronic obstructive pulmonary disease. Most studies did not report harms related to PGHD interventions; the relatively few harms reported were minor and transient, with event rates usually comparable to harms in the control groups. Few studies reported cost-effectiveness analyses, and only for PGHD interventions for hypertension, coronary artery disease, and chronic obstructive pulmonary disease; the findings were variable across different chronic conditions and devices. Patient adherence to PGHD interventions was highly variable across studies, but patient acceptance/satisfaction and usability was generally fair to good. However, device engineers independently evaluated consumer wearable and handheld BP monitors and considered the user experience to be poor, while their assessment of smartphone-based electrocardiogram monitors found the user experience to be good. Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed and relatively easy to use. Implications. Multiple randomized controlled trials (RCTs) have evaluated some PGHD technologies (e.g., pedometers, scales, BP monitors), particularly for obesity and hypertension, but health outcomes were generally underreported. We found evidence suggesting a possible positive effect of PGHD interventions on health outcomes for four chronic conditions. Lack of reporting of health outcomes and insufficient statistical power to assess these outcomes were the main reasons for “unclear” ratings. The majority of studies on PGHD technologies still focus on non-health-related outcomes. Future RCTs should focus on measurement of health outcomes. Furthermore, future RCTs should be designed to isolate the effect of the PGHD intervention from other components in a multicomponent intervention.
APA, Harvard, Vancouver, ISO, and other styles
6

Uhl, Stacey, Shazia Mehmood Siddique, Liam McKeever, Aaron Bloschichak, Kristen D’Anci, Brian Leas, Nikhil K. Mull, and Amy Y. Tsou. Malnutrition in Hospitalized Adults: A Systematic Review. Agency for Healthcare Research and Quality (AHRQ), October 2021. http://dx.doi.org/10.23970/ahrqepccer249.

Full text
Abstract:
Objectives. To review the association between malnutrition and clinical outcomes among hospitalized patients, evaluate effectiveness of measurement tools for malnutrition on clinical outcomes, and assess effectiveness of hospital-initiated interventions for patients diagnosed with malnutrition. Data sources. We searched electronic databases (Embase®, MEDLINE®, PubMed®, and the Cochrane Library) from January 1, 2000, to June 3, 2021. We hand-searched reference lists of relevant studies and searched for unpublished studies in ClinicalTrials.gov. Review methods. Using predefined criteria and dual review, we selected (1) existing systematic reviews (SRs) to assess the association between malnutrition and clinical outcomes, (2) randomized and non-randomized studies to evaluate the effectiveness of malnutrition tools on clinical outcomes, and (3) randomized controlled trials (RCTs) to assess effectiveness of hospital-initiated treatments for malnutrition. Clinical outcomes of interest included mortality, length of stay, 30-day readmission, quality of life, functional status, activities of daily living, hospital acquired conditions, wound healing, and discharge disposition. When appropriate, we conducted meta-analysis to quantitatively summarize study findings; otherwise, data were narratively synthesized. When available, we used pooled estimates from existing SRs to determine the association between malnutrition and clinical outcomes, and assessed the strength of evidence. Results. Six existing SRs (including 43 unique studies) provided evidence on the association between malnutrition and clinical outcomes. Low to moderate strength of evidence (SOE) showed an association between malnutrition and increased hospital mortality and prolonged hospital length of stay. This association was observed across patients hospitalized for an acute medical event requiring intensive care unit care, heart failure, and cirrhosis. Literature searches found no studies that met inclusion criteria and assessed effectiveness of measurement tools. The primary reason studies did not meet inclusion criteria is because they lacked an appropriate control group. Moderate SOE from 11 RCTs found that hospital-initiated malnutrition interventions likely reduce mortality compared with usual care among hospitalized patients diagnosed with malnutrition. Low SOE indicated that hospital-initiated malnutrition interventions may also improve quality of life compared to usual care. Conclusions. Evidence shows an association between malnutrition and increased mortality and prolonged length of hospital stay among hospitalized patients identified as malnourished. However, the strength of this association varied depending on patient population and tool used to identify malnutrition. Evidence indicates malnutrition-focused hospital-initiated interventions likely reduce mortality and may improve quality of life compared to usual care among patients diagnosed with malnutrition. Research is needed to assess the clinical utility of measurement tools for malnutrition.
APA, Harvard, Vancouver, ISO, and other styles
7

Qiu, Mei, Liang-Liang Ding, and Hai-Rong Zhou. Meta-analyzing the factors affecting the efficacy of SGLT2is on heart failure events based on cardiovascular outcome trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2020. http://dx.doi.org/10.37766/inplasy2020.11.0094.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Peng, Na jia, Bing Liu, and Qing He. Effect of cardiac shock wave therapy on adverse cardiovascular event for patients with coronary artery disease: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0103.

Full text
Abstract:
Review question / Objective: We have previously demonstrated that cardiac shock wave therapy (CSWT) effectively improves myocardial perfusion in patients with coronary artery disease (CAD). In this study, we want to address whether CSWT could decrease the risk of adverse cardiovascular events in CAD patients unsuitable for revascularization. Eligibility criteria: Trials are considered eligible if they meet these criteria: (1) patients included are diagnosed as refractory angina or ischemic heart failure; (2) the study i a randomized controlled trial (RCT) or a prospective cohort study; (3) intervention consisted of CSWT; (4) patients in the control group are treated with optimal medical therapy, (5)the primary outcome of interest Is rate of MACE. Exclusion criteria were (1) patients with acute myocardial infarction, (2) repeated CSWT, (3) with coronary artery revascularization, (4) without primary outcome, (5) retrospective study, and (6)duplicated data.
APA, Harvard, Vancouver, ISO, and other styles
9

Treewaree, Sukrit, Narathorn Kulthamrongsri, Weerapat Owattanapanich, and Rungroj Krittayaphong. Sodium-glucose cotransporter-2 inhibitors reduce cardiovascular outcome and improve health status in Heart failure with preserved ejection fraction: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

The heart failure drug levosimendan doesn’t improve outcomes in adults with severe infections. National Institute for Health Research, December 2016. http://dx.doi.org/10.3310/signal-000347.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Heart failure outcomes' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography